Skip to main content

1 Result(s)

within English Remove this filter Medicine & Public Health Remove this filter Cancer Research Remove this filter Hematology Remove this filter H Knoth Remove this filter Article Remove this filter

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia

Include preview-only content

  1. Article

    Open Access

    Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

    This study evaluated azacitidine as treatment of minimal residual disease (MRD) determined by a sensitive donor chimerism analysis of CD34+ blood cells to pre-empt relapse in patients with CD34+ myelodysplastic s...

    U Platzbecker, M Wermke, J Radke, U Oelschlaegel, F Seltmann, A Kiani, I-M Klut… in Leukemia (2012)

    Download PDF (1546 KB) View Article